Electromed, INC 8-K filings

Electromed, Inc. announced record financial results for its third quarter of fiscal year 2026, with an 18.4% increase in net revenues and a 76.0% surge in operating income.

Electromed, Inc. reported record net revenues and net income for its fiscal second quarter ended December 31, 2025, marking its thirteenth consecutive quarter of year-over-year growth.

Electromed, Inc. has entered into a new $10 million revolving credit facility with BMO Bank N.A., replacing its previous credit arrangement.

Electromed, Inc. shareholders approved the election of eight directors, ratified RSM US LLP as auditor, and endorsed executive compensation at their annual meeting on November 14, 2025.

Electromed, Inc. announced robust first quarter fiscal 2026 results, marking its twelfth consecutive quarter of year-over-year revenue and net income growth, driven by strong operational execution and market expansion.

Electromed, Inc. announced its Board of Directors authorized a new share repurchase program of up to $10.0 million of common stock, signaling confidence in its financial health.

Electromed, Inc. announced record net revenue and operating income for both the fourth quarter and full fiscal year 2025, marking its eleventh consecutive quarter of growth.

Electromed reports a 13.1% increase in net revenue and a 16.2% increase in operating income for Q3 FY2025, continuing its streak of year-over-year growth.

Electromed's board of directors has authorized the repurchase of up to $5 million of the company's common stock.

Electromed reports record revenue and earnings for Q2 FY 2025, driven by strong sales growth and strategic investments.

Electromed, Inc. held its annual shareholder meeting, adopted amended bylaws, and elected directors for the coming year.

Electromed announced its first quarter fiscal year 2025 financial results, highlighting an 19% increase in net revenue and significant profit growth.

Electromed's board of directors has authorized a new share repurchase program of up to $5 million, following the completion of a previous program and a record fiscal year.

Electromed reports record financial results for fiscal year 2024, with significant increases in revenue, operating income, and net income.

Electromed, Inc. has released an updated investor presentation and announced its participation in the Canaccord Genuity 44th Annual Global Growth Conference.

Electromed reports record revenue of $13.9 million for the third quarter of fiscal year 2024, a 15% increase compared to the same period last year.

Electromed reports record revenue and improved profitability for the second quarter of fiscal year 2024, driven by growth initiatives and operational efficiencies.